Introduction
============

ENKTL is an aggressive non-Hodgkin lymphoma that most frequently occurs in East Asia and Latin America, with an increasing incidence in the United States ([@B1]). ENKTL usually arises in the nasal cavity, but extra-nasal sites are involved including skin, soft tissue, and gastrointestinal tract ([@B2]). The neoplastic cells are various in morphology from small or medium-to-large populations with reactive inflammatory cells. The clinical and pathological variability could mislead and delay the diagnosis. We report here a case of ENKTL who manifested generalized muscle weakness and mimicked granulomatous myositis.

Case Report
===========

A 54-year-old previously healthy Japanese man presented with generalized muscle weakness in all 4 limbs. Three months later, he developed diplopia and was admitted to our department. He also presented with erythema around the eyes, facial edema, and a low-grade fever. A neurological examination revealed external limitation of the eye movement in the right eye, bilateral eyelid swelling, facial weakness, jaw claudication, dysarthria, dysphagia, and proximal-dominant muscle weakness in four limbs (Medical Research Council grade 4) with grasping pain. Laboratory investigations showed elevated muscle enzymes \[creatine kinase (CK), 796 U/L; myoglobin, 1,021 ng/mL\]. The serum lactate dehydrogenase (LDH) level was mildly elevated (529 U/L). Lysozyme and angiotensin-converting enzyme (ACE) values were within normal limits. Anti-signal recognition particle and anti-aminoacyl transfer RNA synthetase antibodies were negative. The serum soluble interleukin-2 receptor (sIL-2R) level was elevated (2,730 U/mL; normal range, ＜519 U/mL).

Needle electromyography revealed low-amplitude, polyphasic motor unit potentials and early recruitments in both distal and proximal muscles and positive sharp waves in the vastus medialis. A nerve conduction study exhibited no abnormality. Muscle magnetic resonance imaging (MRI) showed high-signal-intensity areas on T2-weighted images in the proximal muscles of all four limbs with gadolinium enhancement in the left upper limb ([Fig. 1A](#g001){ref-type="fig"}). Brain MRI findings were normal, including examinations of the orbits and cranial nerves. Whole-body computed tomography (CT) and gallium scintigraphy showed no abnormalities.

![A: Axial muscle MRI of the left upper limb showed hyperintense lesions in T2-weighted, T2 fat-suppressed (T2FS) and T1 gadolinium-enhanced fat-suppressed (T1Gd) images. B: FDG-PET showed the diffuse accumulation in the muscles of all four extremities and the accumulation in the right thigh (arrow).](1349-7235-58-0277-g001){#g001}

A muscle biopsy of left biceps brachii on frozen sections revealed massive infiltration of lymphocytes forming granuloma-like structures in the endomysium, preferentially at the center of muscle bundles and around the vessels in the perimysium ([Fig. 2C](#g002){ref-type="fig"}). Necrotic myofibers were scattered around the granuloma-like structures. Epithelioid cells, giant cells, and caseous necrosis were not observed. Alkaline phosphatase staining showed intensely stained perimysial areas, but there was no staining in the granuloma-like structures ([Fig. 2D](#g002){ref-type="fig"}). Immunostaining for HLA-class I, CD3, CD4, CD8, CD68, and CD20 revealed diffuse overexpression of HLA-class I on sarcolemma, predominantly CD4-positive lymphocytes and smaller numbers of CD8+ and CD20+ lymphocytes forming the granuloma-like structures. Increased numbers of CD68+ cells were found to be diffusely scattered in the endomysial and interstitial regions. Further immunohistochemical analyses with additional markers including CD34 staining revealed increased numbers of dilated capillaries among the granuloma-like structures ([Fig. 2I](#g002){ref-type="fig"}). In addition, a skin biopsy of the facial erythema showed lymphocytic infiltrations without atypia prominently in the basal layers of the epidermis and mildly in the superficial layers. Massive lymphocytic infiltration was also observed around the vessels in the deep layers of the epidermis. Based on these findings, we diagnosed the case as atypical myositis with granuloma-like structures and decided to try immunotherapy.

![A: A muscle biopsy of the left biceps brachii showing massive infiltration of lymphocytes in the endomysium \[Hematoxylin and Eosin (H&E) staining, bar=200 µm\]. B: Lymphocytes infiltrated into the myofibers and formed necrosis (H&E staining, bar=50 µm). C: High magnification of the granuloma-like structures revealed a high density of lymphocytes with a large nucleus. Neither epithelioid cells nor giant cells were observed (H&E staining, bar=20 µm). D: The perimysial area was intensely stained with alkaline phosphatase staining (bar=100 µm). E: Human leukocyte antigen class I (HLA-class I) was diffusely overexpressed on sarcolemma. The granuloma-like structures were composed of cells positive for CD4 (F), CD8 (G), CD68 (H), CD56 (J), and cytoplasmic CD3 (K). CD34-positive dilated capillaries were observed among the granuloma-like structures (I). Nearly 60% of dikaryotic lymphocytes were positive for Ki-67 (L). Bars=50 µm (E, I), 100 µm (F-H, J-L).](1349-7235-58-0277-g002){#g002}

After administering oral prednisolone (1 mg/kg/day), all of his symptoms disappeared within 2 weeks. The serum CK and LDH levels were normalized, and the serum sIL-2R level decreased to 538 U/mL. Subsequently, oral prednisolone was tapered to 30 mg/day over the next 2 months. However, three months after initiating prednisolone, generalized muscle weakness recurred followed by a high fever and weight loss. The serum CK and sIL-2R levels were elevated to 401 IU/L and 5,140 U/mL, respectively. The serum LDH level was also increased (564 U/L). Whole-body CT detected hepatosplenomegaly and pleural effusion without lymph node enlargement, and an ulcerative eruption developed on his right thigh. A skin biopsy of the lesion revealed massive cell infiltration with atypia in the dermis ([Fig. 3](#g003){ref-type="fig"}). These cells were stained positive for CD3, CD56, Epstein-Barr Virus (EBV)-encoded small RNA (EBER)*in situ* hybridization (ISH), Granzyme B, and T-cell-restricted intracellular antigen-1, establishing the diagnosis of EBV-related ENKTL.

![A skin biopsy from ulcerative eruption on the right thigh showed the infiltration of neoplastic lymphoid cells positive for CD3 (B), CD56 (C), and EBER-ISH (D) in the dermis. \[Hematoxylin and Eosin staining (A), bar=50 µm\].](1349-7235-58-0277-g003){#g003}

A re-evaluation of the muscle biopsy specimen revealed that most lymphocytes in the granuloma-like structures had mild atypia with a Ki-67 index of up to 60% and were positive for CD56, CD3, and focally CD5 ([Fig. 2L](#g002){ref-type="fig"}). Positron emission tomography (PET)-CT showed the accumulation of ^18^F-fluorodeoxyglucose (FDG) in the ulcerative eruption on his right thigh (SUV maximum of 3.5) and generalized FDG accumulation in the skeletal muscles (SUV maximum of 3.6) ([Fig. 1B](#g001){ref-type="fig"}). EBV DNA was elevated in the blood (6,000 copies/μg DNA), and rearrangements in T-cell receptor genes were not observed. The ultimate diagnosis was ENKTL invasion in the muscles with chronic active EBV disease. Therapeutically, combination chemotherapy with steroids, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE regimen) and hematopoietic stem cell transplantation were attempted. However, his general condition deteriorated, and he died due to sepsis. An autopsy was not performed.

Discussion
==========

ENKTL usually arises in the nasal cavity or surrounding structures, such as the sinuses or palate. Only seven cases of ENKTL that manifested myopathic symptoms have been reported, and they were all initially diagnosed as myositis ([Table](#t001){ref-type="table"}) ([@B3]-[@B9]). Clinically, all of the cases except our own exhibited localized lesions as the initial symptom. However, these lesions did not show a tendency to be located in the proximal regions of the four limbs. Only our case showed generalized muscle weakness with proximal-dominance. The diagnoses based on muscle biopsies were not homogeneous in the previous cases (Table). One case was considered to be sarcoid myositis because of the presence of granulomatous structures ([@B4]). Three cases were diagnosed as polymyositis ([@B5], [@B6], [@B8]). Another case was clinically suspected of being dermatomyositis since the patient had skin lesions ([@B3]). These previous findings along with our own suggest that ENKTL can present various clinicopathological patterns and should be considered as a differential diagnosis in patients with atypical myopathic symptoms.

The systemic symptoms, including eyelid swelling and facial edema, may have been caused by direct invasion of the tumorous cells and paraneoplastic mechanism. Previous reports have shown that the eyelid and facial swellings were caused by the direct invasion of lymphocytes into the muscles ([@B10], [@B11]). Furthermore, some cases of ENKTL with myopathic symptoms were reported to exhibit bilateral eyelid swellings ([@B8], [@B9]). Thus, symptoms such as eyelid swelling and facial edema can occur along with muscle weakness in ENKTL. Therapeutically, the initial response to steroid was outstanding in our case. Previous cases of ENKTL with myopathic symptoms showed a temporary encouraging response at the early phase but became refractory later ([Table](#t001){ref-type="table"}). The possibility of malignancy should therefore be considered when such a therapeutic response is recognized.

###### 

Comparisons with the Previous Cases of ENKTL That Manifested Myopathic Symptoms.

                                          Our case                                                                                     Ref 5                                                                                                            Ref 3                                                                                   Ref 8                                                                                                              Ref 2                                                                                                                Ref 4                                                                                                                               Ref 6                                                                                       Ref 7
  --------------------------------------- -------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------
  Age/sex                                 54/Male                                                                                      53/Male                                                                                                          34/Female                                                                               50/Female                                                                                                          68/Female                                                                                                            38/Male                                                                                                                             52/Female                                                                                   57/Female
  Muscle involvement                      generalized muscle, face, jaw, pharynx                                                       Rt LL                                                                                                            Rt forearm                                                                              Both ULs, Lt thigh, Rt rectus                                                                                      Rt forearm, face                                                                                                     Both LLs                                                                                                                            Both LLs, buttock, Rt forearm, face                                                         cardiac muscle
  Other organs involved                   eyelids, face, oral cavity, skin, liver, spleen                                              nasal cavity, skin                                                                                               liver                                                                                   eyelids, oral cavity, Lt thigh, Lt breast                                                                          lung and oropharynx                                                                                                  palate, inguinal LN, skin                                                                                                           lung                                                                                        eyelids, lung, liver, spleen
  Prognosis                               death                                                                                        death                                                                                                            death                                                                                   death                                                                                                              death                                                                                                                death                                                                                                                               death                                                                                       death
  Survival from initial onset             19 months                                                                                    8 months                                                                                                         not available                                                                           72 months                                                                                                          1.5 months                                                                                                           8 months                                                                                                                            26 months                                                                                   36months
  Initial symptom                         generalized muscle weakness including face and mouth, eyelid erythema, facial edema, fever   localized muscle swelling in Rt LL                                                                               Rt forearm swelling, fever                                                              muscle weakness of ULs, swelling of eyelids and lip                                                                Rt forearm swelling, facial edema                                                                                    mucocutaneous ulcer in LLs                                                                                                          swelling and pain in LLs                                                                    eyelid swelling, fever
  Muscle pathology                        massive infilration of lymphocyte among muscle bundles, epitheloid or giant cell(-)          infiltration of mononuclear inflammatory cells with massive destruction of muscle fibers, scattered granulomas   patchy infiltration of the perimysium and endomysium with medium-sized lymphoid cells   mild infiltration of small lymphocytes among mucle fiber bundles, regeneration and degeneration of muscle fibers   a multifocal, chronic inflammatory infiltrate of small lymphocytes without atypia, scattered muscle fiber necrosis   diffuse necrosis and massive destruction of the muscle fibers, many aggregating large atypical lyphoid cells with angiocentricity   Eosinophilic infiltration with lymphocytes showing mild atypia. A few vague granulomas(+)   a dense perivascular and intermuscular lymphoid infilatration consisting of atypical cells
  IHC on muscle specimen                  lymphocytes positive for CD56, CD3, focally CD5                                              scattered lymphoid cells positive for CD56 and CD30                                                              lymphocytes positive for CD3ε, CD8, CD45RO, CD56 and EBER                               lymphocytes positive for CD3ε, CD8, TIA-1 and EBER-1                                                               not performed                                                                                                        cytoplasmic CD3(+), CD56(+), Granzyme B(+), CD30(+), EBER(+)                                                                        admixed CD3(+) cells and CD20(+) cells                                                      EBER(+)
  Initial diagnosis after muscle biopsy   GM, atypical                                                                                 GM, atypical                                                                                                     PM                                                                                      PM                                                                                                                 PM (Burkitt lymphoma was already treated)                                                                            not conclusive (DM was clinically suspected)                                                                                        Kimura disease                                                                              CAEBV-associated lymphoma
  Response to initial steroid treatment   rapid resolution of all the symptoms                                                         not available                                                                                                    resolution of the symptoms                                                              transient response                                                                                                 not responsive                                                                                                       not responsive to chemotherapy                                                                                                      resolution of symptoms                                                                      transient response

UL: upper limb, LL: lower limb, LN: lymph nodes, Rt: right, Lt: left, GM: granulomatous myositis, PM: polymyositis, DM: dermatomyositis, CAEBV: chronic active Epstein-Barr virus infection

Granulomatous myositis is characterized by non-necrotizing granuloma and is frequently associated with sarcoidosis ([@B12], [@B13]). Initially, we diagnosed this case as atypical granulomatous myositis for the following reasons: 1) clinically symmetric generalized muscle weakness was evident as an initial manifestation; 2) systemic organ involvements were observed, including eyelid swelling, diplopia, dysarthria, and dysphagia; and 3) the muscular histological findings of the granuloma-like structures composed of CD4+ lymphocytes and CD68+ cells surrounded by CD8+ lymphocytes resembled sarcoid myositis ([@B14]). However, several features were not typical of sarcoidosis, such as the normal serum ACE level, lack of hilar lymph node enlargement, and the granuloma-like structures not containing epithelioid cells, giant cells, or clusters of CD68-positive cells which mimic but are not actual granulomas. Although our case exhibited heliotrope rash-like lesion and an alkaline phosphatase positive perimysial area, which is characteristic of antisynthetase syndrome ([@B15]), the muscle pathology was not entirely consistent with dermatomyositis. The case was therefore initially diagnosed as atypical myositis associated with unknown etiology.

However, additional immunostaining of a muscle biopsy specimen ultimately revealed that the granuloma-like structures predominantly contained CD56-positive NK/T cells and relatively few CD4-positive T cells. This cellular composition can be interpreted as the invasion of NK/T lymphomas into the skeletal muscles and subsequent inflammatory aggregation of CD4-positive T cells. Such admixed inflammatory infiltration is a characteristic feature of ENKTL reported in other tissues ([@B16]), which may lead to the misdiagnosis of granulomatous myositis in cases with limited immunostaining findings. Furthermore, we were unable to detect mild lymphocyte atypia initially because it is challenging to discriminate mild atypia on frozen sections ([@B5]). Immunohistochemical evaluations on both frozen and paraffin-embedded sections along with an assessment of nuclear atypia might have helped us diagnose the present case earlier. These findings therefore suggest that evaluating the biopsy specimen on paraffin-embedded sections with extensive immunohistochemistry is necessary for the precise diagnosis of atypical myositis.

The primary lesion of the malignant lymphoma was not identified in our case. PET-CT showed the uniform accumulation in systemic muscles, suggesting a primary occult lesion and possible hematogenous metastasis to and proliferation in the skeletal muscles. Furthermore, a muscle biopsy revealed that lymphoma cells were predominantly distributed in the middle of each muscle bundle with increased and dilated capillaries. This pattern may reflect an angiocentric tendency of ENKTL cells ([@B16]).

In summary, we herein report a case of ENKTL mimicking granulomatous myositis. It is difficult to appropriately diagnose such an atypical myositis based on a muscle biopsy with limited immunohistochemical markers. Combined approaches of ([@B1]) careful clinical evaluations ([@B3]), repeated biopsies, and ([@B4]) a review of the previous biopsy specimen with a broad panel of immunohistochemical markers, are imperative for the precise characterization of atypical myositis.
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